Evaluation of the Safety, Tolerability, PK of TBAJ-587 in Healthy Adults
Status:
Recruiting
Trial end date:
2023-03-23
Target enrollment:
Participant gender:
Summary
Phase 1, Partially Blinded, Placebo-Controlled, Randomized, Combined Single Ascending Dose
with Food Effect Cohort Trial (Part 1) and Multiple Ascending Dose Trial (Part 2) to Evaluate
the Safety, Tolerability, and PK of TBAJ-587 in Healthy Adults